Atlas FDA

VISCO-3

FDA premarket approval P980044/S027 · decided 2015-12-21

Approval details

PMA number
P980044
Supplement
S027
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
VISCO-3
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2015-07-08
Decision date
2015-12-21
Days to decision
166 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
APPROVAL FOR VISCO-3. THIS DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGIC THERAPY AND SIMPLE ANALGESICS, E.G., ACETAMINOPHEN.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15